Literature DB >> 11337319

Tuning in on tumor activity with proton MR spectroscopy.

L A Kwock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11337319      PMCID： PMC8174954     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  4 in total

Review 1.  Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors.

Authors:  M Castillo; L Kwock
Journal:  Top Magn Reson Imaging       Date:  1999-04

2.  Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas.

Authors:  H Shimizu; T Kumabe; R Shirane; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

3.  Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis.

Authors:  J S Taylor; J W Langston; W E Reddick; P B Kingsley; R J Ogg; M H Pui; L E Kun; J J Jenkins; G Chen; J J Ochs; R A Sanford; R L Heideman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-12-01       Impact factor: 7.038

4.  Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.

Authors:  M C Preul; Z Caramanos; J G Villemure; G Shenouda; R LeBlanc; A Langleben; D L Arnold
Journal:  Neurosurgery       Date:  2000-02       Impact factor: 4.654
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.